These results suggest that loss of DAB2IP in Luminal A breast cancer leads to increased NF-κB signaling and an increase in the expression of genes that are proproliferative and protumorigenic, thereby making this subset of Luminal A tumors more aggressive. This evidence concerns the gene DAB2IP and breast carcinoma.